Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

Nicole Thomas, Kostiantyn Dreval, Daniela S. Gerhard, Laura K. Hilton, Jeremy S. Abramson, Richard F. Ambinder, Stefan Barta, Nancy L. Bartlett, Jeffrey Bethony, Kishor Bhatia, Jay Bowen, Anthony C. Bryan, Ethel Cesarman, Corey Casper, Amy Chadburn, Manuela Cruz, Dirk P. Dittmer, Maureen A. Dyer, Pedro Farinha, Julie M. Gastier-Foster, Alina S. Gerrie, Bruno M. Grande, Timothy Greiner, Nicholas B. Griner, Thomas G. Gross, Nancy L. Harris, John D. Irvin, Elaine S. Jaffe, David Henry, Rebecca Huppi, Fabio E. Leal, Michael S. Lee, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Ronald Mitsuyasu, Vivian Morris, Charles G. Mullighan, Andrew J. Mungall, Karen Mungall, Innocent Mutyaba, Mostafa Nokta, Constance Namirembe, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, German Ott, Hilary Petrello, Stefania Pittaluga, James D. Phelan, Juan Carlos Ramos, Lee Ratner, Steven J. Reynolds, Paul G. Rubinstein, Gerhard Sissolak, Graham Slack, Shaghayegh Soudi, Steven H. Swerdlow, Alexandra Traverse-Glehen, Wyndham H. Wilson, Jasper Wong, Robert Yarchoan, Jean C. ZenKlusen, Marco A. Marra, Louis M. Staudt, David W. Scott, Ryan D. Morin

Blood (2023) 141 (8): 904–916.

https://doi.org/10.1182/blood.2022016534

Published: 2023

Includes: Supplemental data

Journal Articles

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Blood (2022) 140 (Supplement 1): 1734–1736.

https://doi.org/10.1182/blood-2022-163728

Published: 2022

Journal Articles

Safety and Tolerability of Sars-Cov-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease

Sheila K Pierson, Russell Perkins, Frits van Rhee, Corey Casper, David C Fajgenbaum

Blood (2021) 138 (Supplement 1): 2696.

https://doi.org/10.1182/blood-2021-153797

Published: 2021

Journal Articles

Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma

Blood (2021) 138 (Supplement 1): 806.

https://doi.org/10.1182/blood-2021-147916

Published: 2021

Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Blood (2019) 134 (Supplement_1): 1540.

https://doi.org/10.1182/blood-2019-131367

Published: 2019

Journal Articles

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Bruno M. Grande, Daniela S. Gerhard, Aixiang Jiang, Nicholas B. Griner, Jeremy S. Abramson, Thomas B. Alexander, Hilary Allen, Leona W. Ayers, Jeffrey M. Bethony, Kishor Bhatia, Jay Bowen, Corey Casper, John Kim Choi, Luka Culibrk, Tanja M. Davidsen, Maureen A. Dyer, Julie M. Gastier-Foster, Patee Gesuwan, Timothy C. Greiner, Thomas G. Gross, Benjamin Hanf, Nancy Lee Harris, Yiwen He, John D. Irvin, Elaine S. Jaffe, Steven J. M. Jones, Patrick Kerchan, Nicole Knoetze, Fabio E. Leal, Tara M. Lichtenberg, Yussanne Ma, Jean Paul Martin, Marie-Reine Martin, Sam M. Mbulaiteye, Charles G. Mullighan, Andrew J. Mungall, Constance Namirembe, Karen Novik, Ariela Noy, Martin D. Ogwang, Abraham Omoding, Jackson Orem, Steven J. Reynolds, Christopher K. Rushton, John T. Sandlund, Roland Schmitz, Cynthia Taylor, Wyndham H. Wilson, George W. Wright, Eric Y. Zhao, Marco A. Marra, Ryan D. Morin, Louis M. Staudt

Blood (2019) 133 (12): 1313–1324.

https://doi.org/10.1182/blood-2018-09-871418

Published: 2019

Includes: Supplemental data

Journal Articles

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

Chloe Stiggelbout, Megan Real-Hall, Innocent Mutyaba, MBChB, MS, Elizabeth M Krantz, Scott Adams, PhD, Thomas S. Uldrick, MD MS, Jackson Orem, MBChB, MMed, PhD, Corey Casper, MD MPH, Suzanne McGoldrick, MD MPH, Steven Kussick, MD

Blood (2018) 132 (Supplement 1): 2271.

https://doi.org/10.1182/blood-2018-99-116263

Published: 2018

Journal Articles

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Blood (2018) 132 (20): 2115–2124.

https://doi.org/10.1182/blood-2018-07-862334

Published: 2018

Includes: Supplemental data

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

Blood (2017) 130 (Supplement 1): 39.

https://doi.org/10.1182/blood.V130.Suppl_1.39.39

Published: 2017

Journal Articles

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Blood (2017) 129 (12): 1646–1657.

https://doi.org/10.1182/blood-2016-10-746933

Published: 2017

Journal Articles

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Daniela S Gerhard, PhD, Bruno Grande, B. Sc., Nicholas Griner, PhD, Corey Casper, MD, Sarah E. Gerdts, MPH, Abraham Omoding, MD, Jackson Orem, MD, Sam M Mbulaiteye, MD, Martin D. Ogwang, MD, Steven J. Reynolds, MD MPH, Kishor Bhatia, PhD, Leona Ayers, MD, John K Choi, MD, Charles G. Mullighan, MBBS, MSc, PhD, John T. Sandlund, MD, Thomas B. Alexander, MD MPH, Jeremy S. Abramson, MD, Thomas G. Gross, MD PhD, Ariela Noy, MD PhD, Jeffrey Bethony, PhD, Fabio Leal, MD, PhD, Timothy C Greiner, MS, MD, Elaine S. Jaffe, MD, Nancy Lee Harris, MD, Julie M. Gastier-Foster, PhD, Jay Bowen, MS, Benjamin Hanf, Roland Schmitz, PhD, Jean-Paul Martin, MD, Marie-Reine Martin, MD, John D. Irvin, MD PhD, Ellen Miller, MS, Patee Gesuwan, Leandro C. Hermida, Tanja M. Davidsen, PhD, Andrew J. Mungall, Yussanne Ma, PhD, Marco A. Marra, PhD, Ryan D. Morin, Louis M. Staudt, MD PhD

Blood (2016) 128 (22): 1760.

https://doi.org/10.1182/blood.V128.22.1760.1760

Published: 2016

Journal Articles

Impact of a Quality Improvement Project on Pediatric Endemic Burkitt Lymphoma Outcomes in Uganda

Suzanne M McGoldrick, MD MPH, Abrahams Omoding, MB ChB, MMed, Sarah E. Gerdts, MPH, Innocent Mutyaba, MB ChB, MMED, Elizabeth Krantz, B.A., M.S., Jackson Orem, MD, Corey Casper, MD

Blood (2016) 128 (22): 156.

https://doi.org/10.1182/blood.V128.22.156.156

Published: 2016

Journal Articles

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

David G. Coffey, MD, Katharine A. Lombardo, BS, Andrea M. H. Towlerton, BS, Sarah E. Gerdts, MPH, Corey Casper, MD, Jackson Orem, MD, Edus H. Warren, III, MD PhD

Blood (2015) 126 (23): 3896.

https://doi.org/10.1182/blood.V126.23.3896.3896

Published: 2015

Journal Articles

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Frits van Rhee, MD PhD, Corey Casper, MD, Margaret K Vernon, PhD, Dylan Trundell, MSc, Don Robinson, MSPH, Jianming He, PhD, Jessica Vermeulen, MD PhD, Helgi van de Velde, MD PhD, Raymond S Wong, MD

Blood (2014) 124 (21): 4469.

https://doi.org/10.1182/blood.V124.21.4469.4469

Published: 2014

Journal Articles

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Katharine Lombardo, Andrea M. H. Towlerton, Alicia Morales, Sarah Gerdts, MPH, Innocent Mutyaba, MD, Abrahams Omoding, MD, Jackson Orem, MD, Erica Sessle, MPH, Corey Casper, MD, Edus Warren, MD PhD

Blood (2014) 124 (21): 1687.

https://doi.org/10.1182/blood.V124.21.1687.1687

Published: 2014

Journal Articles

Treatment Recommendations for Patients with NHL at the Uganda Cancer Institute

Manoj P Menon, MD, MPH, Anna Coghill, PhD, Innocent Mutyaba, MD, Fred Okuku, MD, Warren Phipps, MD, MPH, John M. Harlan, MD, Jackson Orem, MD, Corey Casper

Blood (2013) 122 (21): 2960.

https://doi.org/10.1182/blood.V122.21.2960.2960

Published: 2013

Journal Articles

An Open-Label, Phase 2, Multicenter Study Of The Safety Of Long-Term Treatment With Siltuximab (an Anti-Interleukin-6 Monoclonal Antibody) In Patients With Multicentric Castleman’s Disease

Frits Van Rhee, Corey Casper, Peter M Voorhees, Luis E Fayad, Helgi van de Velde, Jessica Vermeulen, Xiang Qin, Ming Qi, Brenda Tromp, Razelle Kurzrock

Blood (2013) 122 (21): 1806.

https://doi.org/10.1182/blood.V122.21.1806.1806

Published: 2013

Journal Articles

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Blood (2013) 122 (21): 505.

https://doi.org/10.1182/blood.V122.21.505.505

Published: 2013

Journal Articles

Meeting the challenge of hematologic malignancies in sub-Saharan Africa

Satish Gopal, William A. Wood, Stephanie J. Lee, Thomas C. Shea, Kikkeri N. Naresh, Peter N. Kazembe, Corey Casper, Peter B. Hesseling, Ronald T. Mitsuyasu

Blood (2012) 119 (22): 5078–5087.

https://doi.org/10.1182/blood-2012-02-387092

Published: 2012

Journal Articles

Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease,

Razelle Kurzrock, MD, Peter M. Voorhees, MD, Corey Casper, MD, Richard R. Furman, MD, Luis Fayad, MD, Sagar Lonial, MD, Hossein Borghaei, DO, Sundar Jagannath, MD, Lubomir Sokol, MD, PhD, Saad Usmani, MD, FACP, Helgi van de Velde, MD, PhD, Xiang Qin, PhD, Ming Qi, MD, PhD, Mark J. Cornfeld, MD, MPH, Frits van Rhee, MD, PhD

Blood (2011) 118 (21): 3959.

https://doi.org/10.1182/blood.V118.21.3959.3959

Published: 2011

NARROW

Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features

Safety and Tolerability of Sars-Cov-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease

Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction

Impact of a Quality Improvement Project on Pediatric Endemic Burkitt Lymphoma Outcomes in Uganda

Comparative Analysis of Endemic and Sporadic Burkitt Lymphoma By RNA Sequencing

Superior Restoration of Health with Siltuximab Among Multicentric Castleman’s Disease Patients When Measured By SF-36

Next Generation Sequencing of B Cell Antigen Receptors Expressed in African Endemic Burkitt Lymphoma

Treatment Recommendations for Patients with NHL at the Uganda Cancer Institute

An Open-Label, Phase 2, Multicenter Study Of The Safety Of Long-Term Treatment With Siltuximab (an Anti-Interleukin-6 Monoclonal Antibody) In Patients With Multicentric Castleman’s Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Meeting the challenge of hematologic malignancies in sub-Saharan Africa

Long-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only